Literature DB >> 3106172

Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues.

A Bennett, A Civier, C N Hensby, P B Melhuish, I F Stamford.   

Abstract

This is the first report of human gastrointestinal arachidonate and prostanoids measured quantitatively by gas chromatography-mass spectrometry (GC-MS) in extracts of human cancers and macroscopically normal tissues from the stomach and colon. There were microgram/g amounts of arachidonate, and the particularly high yield from the tumours may explain why they usually produce more prostaglandins than the normal tissues in which they arise. There was only a small conversion of the arachidonate into prostanoids. 6-Keto-PGF1 alpha was the most abundant metabolite measured, particularly in the tumour extracts, with smaller amounts of prostaglandins E2, F2 alpha and D2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106172      PMCID: PMC1432696          DOI: 10.1136/gut.28.3.315

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Stimulation of prostaglandin biosynthesis by vasoactive substances in methylcholanthrene-transformed mouse BALB/3T3.

Authors:  S L Hong; R Polsky-Cynkin; L Levine
Journal:  J Biol Chem       Date:  1976-02-10       Impact factor: 5.157

Review 2.  Prostaglandins and cancer: an update.

Authors:  B M Jaffe
Journal:  Prostaglandins       Date:  1974-06-25

3.  Preparative thin-layer and column chromatography of prostaglandins.

Authors:  N H Anders
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

4.  Occurrence of prostaglandin E2 in the human stomach, and a study of its effects on human isolated gastric muscle.

Authors:  A Bennett; J G Murray; J H Wyllie
Journal:  Br J Pharmacol Chemother       Date:  1968-02

5.  Human rectal mucosa generates prostacyclin.

Authors:  H Sinzinger; K Silberbauer; M Winter; H Seyfried
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

6.  Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa.

Authors:  B M Peskar; H W Seyberth; B A Peskar
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

7.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

8.  Prostaglandin E2 and gastric acid secretion in man.

Authors:  A Bennett; I F Stamford; W G Unger
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

9.  Estimation and characterization of prostaglandins in the human gastrointestinal tract.

Authors:  A Bennett; I F Stamford; H L Stockley
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

10.  Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.

Authors:  N K Boughton-Smith; C J Hawkey; B J Whittle
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

View more
  13 in total

1.  Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis.

Authors:  R Bartolí; F Fernández-Bañares; E Navarro; E Castellà; J Mañé; M Alvarez; C Pastor; E Cabré; M A Gassull
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Low diacylglycerol values in colonic adenomas and colorectal cancer.

Authors:  G Sauter; A Nerlich; U Spengler; R Kopp; A Pfeiffer
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 3.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

4.  Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence.

Authors:  F Fernández-Bañares; M Esteve; E Navarro; E Cabré; J Boix; A Abad-Lacruz; J Klaassen; R Planas; P Humbert; C Pastor; M A Gassull
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

5.  Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

Authors:  C Gustafson-Svärd; I Lilja; O Hallböök; R Sjödahl
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

6.  Production of prostaglandin E by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue.

Authors:  F Culo; I Klapan; V Katić; T Kolak; B Bakula
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

7.  Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study.

Authors:  Ajoy Dias; Cesar Garcia; Marek Majewski; Grzegorz Wallner; Richard W McCallum; Cezary Poplawski; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2011-06-22       Impact factor: 3.199

8.  Prognostic significance of cytosolic phospholipase A2 expression in patients with colorectal cancer.

Authors:  Young Sun Yoo; Sung Chul Lim; Kyung Jong Kim
Journal:  J Korean Surg Soc       Date:  2011-06-09

9.  Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study.

Authors:  Randall E Harris; Joanne Beebe-Donk; Galal A Alshafie
Journal:  Int J Biol Sci       Date:  2007-06-13       Impact factor: 6.580

10.  Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.

Authors:  K Matsunaga; N Yoshimi; Y Yamada; M Shimizu; K Kawabata; Y Ozawa; A Hara; H Mori
Journal:  Jpn J Cancer Res       Date:  1998-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.